Bial
Manufacturing · Portugal · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
Avenida Da Siderurgia Nacional, Trofa, P...Phone Number
+351 229866100Website
www.bial.comRevenue
$303.8 MillionIndustry
About Bial
Bial Org Chart
Is Bial your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check out if Bial is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Bial
Bial, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Bial launches new products
Earning: See what the market has to say on Bial recently announced quarterly report
Click to see if Bial had a recent Job posting/layoffs
Check if Bial has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Bial has new funding data
Recommended Actions
Find VP level buyers at Bial
Find more new buyers
Company Profile Activity
Activity Insights
Bial is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Bial is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Bial.
Bial Tech Stack
A closer look at the technologies used by Bial
Most Recent Scoops
Bial News & Media
Fairfax India purchases additional 10% stake in India's BIAL for $255m - Airport Technology
Fairfax India has completed the acquisition of an additional 10% equity interest in Bangalore International Airport Limited (BIAL)BIAL Announces First Patient Out in its Phase 2 Clinical Trial of BIA 28-6156 - a Novel Therapy for GBA1 Parkinson's Disease
PORTO, Portugal, Jan. 7, 2025 /PRNewswire/ -- BIAL, a hundred-year-old innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, announced that the first patient has completed the full dose regimen in the ACTIVATE Phase 2 study. BIA 28-6156 is a...BIAL Announces First Patient Out in its Phase 2 Clinical Trial of BIA 28-6156 - a Novel Therapy for GBA1 Parkinson's Disease
PORTO, Portugal, Jan. 7, 2025 /PRNewswire/ -- BIAL, a hundred-year-old innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, announced that the first patient has completed the full dose regimen in the ACTIVATE Phase 2 study. BIA 28-6156 is a...Fairfax India to buy additional 10% stake in Bengaluru airport operator BIAL
The second and third installments are to be paid on or around August 31, 2025 and July 31, 2026, respectively.
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Bial
Bial is a family-owned pharmaceutical company with over 100 years of history, dedicated to patient welfare and focused on research and development. The company specializes in areas such as Parkinson's disease and epilepsy, aiming to improve health outcomes through innovative solutions. Bial has a global presence and is committed to sustainability,... Read More